Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Major Study Examines Endoscopies that Fail to Detect Esophageal Cancer

By HospiMedica International staff writers
Posted on 06 Nov 2025

Barrett’s esophagus—the only known precancerous condition for esophageal adenocarcinoma—develops when chronic acid reflux damages the esophageal lining. More...

Endoscopies are typically used to monitor such patients for precancerous or cancerous lesions. Now, new research suggests that even this gold-standard procedure can sometimes miss early-stage disease.

The study, conducted at the University of Colorado Cancer Center (Aurora, CO, USA), found that nearly one in four esophageal cancers may go undetected during an initial endoscopy. The findings, which have been accepted for publication in Clinical Gastroenterology and Hepatology, underline the urgent need to improve detection standards and quality metrics for endoscopic examinations.

The study analyzed data from 15,178 individuals newly diagnosed with Barrett’s esophagus between 2006 and 2020 in Finland and Sweden. Researchers found that 22% of cancers were classified as post-endoscopy esophageal cancers (PEECs)—diagnosed 30 days to one year after a negative endoscopy. An additional 18% were detected within 30 days of the initial exam, and 60% appeared more than a year later. Hospitals with higher initial detection rates had significantly fewer missed cancers, indicating that variability in examination quality plays a major role in diagnostic accuracy.

The researchers also identified several reasons for missed cancers, including inconsistent adherence to the Seattle biopsy protocol, inadequate inspection time of the Barrett’s segment, and difficulty recognizing subtle or flat lesions. They note that rapidly progressing cancers may still evade detection, even in high-quality exams.

The study calls for establishing quality benchmarks for upper endoscopy—similar to the “adenoma detection rate” used in colonoscopy—to measure how effectively physicians detect early esophageal changes. The researchers emphasize that high-quality examinations involve using advanced imaging, structured biopsy protocols, and sufficient inspection time for each case.

“Our findings highlight the importance of a high-quality endoscopic examination for patients when they get diagnosed with Barrett’s esophagus, including using the best endoscope available, spending adequate time inspected the Barrett’s segment, and ensuring that we take samples using a structured biopsy protocol,” said Sachin Wani, MD, a University of Colorado Cancer Center member who led the research.

Related Links:
University of Colorado Cancer Center


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
ow Frequency Pulse Massager
ET10 L
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.